UPDATE: The slides [PDF] and video for this webinar are now available.
I’m pleased to announce that the Centers of Biomedical Research Excellence (COBRE) Phase 2 funding opportunity announcement (FOA) (PAR-22-163) has been reissued. The COBRE program supports the establishment and development of innovative biomedical and behavioral research centers at Institutional Development Award (IDeA)-eligible institutions. The goal of this FOA is to strengthen successful Phase 1 centers through further research infrastructure improvements and continued development of investigators with shared scientific interests who can compete effectively for independent research funding.
Application receipt date: September 27, 2022
Earliest start date: July 2023
We strongly encourage all Phase 1 COBRE awardees and institutional officials to attend our upcoming webinar:
Thursday, May 12, 3:00-4:30 p.m. ET
Zoom Meeting link
Meeting ID: 160 214 1196
If you’re unable to attend online, you can join by calling 669-254-5252 or 551-285-1373 (United States) and entering the meeting ID and passcode.
During the webinar, we’ll present an overview of the COBRE Phase 2 program’s objectives and go over changes from the prior FOA, emphasizing eligibility and reporting requirements, and other key aspects of PAR-22-163. We’ll also answer your questions.
Participants are encouraged to submit questions prior to the webinar by contacting me no later than May 5. Those requiring sign language interpretation and/or other reasonable accommodations should use our contact form to request accommodations at least 5 days prior to the webinar.
The webinar and presentation slides will be posted on the COBRE webpage following the event.